Narayana Hrudayalaya Ltd
Narayana Hrudalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations.[1]
- Market Cap ₹ 35,240 Cr.
- Current Price ₹ 1,724
- High / Low ₹ 1,873 / 1,080
- Stock P/E 81.7
- Book Value ₹ 107
- Dividend Yield 0.23 %
- ROCE 19.4 %
- ROE 21.4 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 43.9% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 19.9%
Cons
- Stock is trading at 16.1 times its book value
- The company has delivered a poor sales growth of 9.90% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap Nifty Smallcap 100
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1,076 | 1,308 | 1,470 | 1,646 | 1,848 | 2,077 | 2,239 | 1,655 | 2,412 | 2,965 | 3,266 | 3,590 | |
960 | 1,182 | 1,295 | 1,427 | 1,664 | 1,881 | 1,971 | 1,676 | 2,146 | 2,471 | 2,656 | 2,919 | |
Operating Profit | 115 | 126 | 175 | 219 | 184 | 196 | 268 | -21 | 266 | 494 | 609 | 672 |
OPM % | 11% | 10% | 12% | 13% | 10% | 9% | 12% | -1% | 11% | 17% | 19% | 19% |
25 | 10 | 2 | 14 | 16 | 17 | 19 | 71 | 104 | 95 | 120 | 142 | |
Interest | 29 | 38 | 23 | 17 | 26 | 43 | 55 | 48 | 45 | 55 | 65 | 88 |
Depreciation | 55 | 64 | 67 | 68 | 78 | 91 | 128 | 123 | 119 | 139 | 161 | 169 |
Profit before tax | 56 | 34 | 86 | 147 | 95 | 79 | 104 | -121 | 206 | 395 | 503 | 557 |
Tax % | 36% | 38% | 34% | 35% | 39% | 37% | 35% | -35% | 35% | 33% | 16% | 23% |
36 | 21 | 57 | 95 | 58 | 50 | 68 | -79 | 134 | 266 | 425 | 431 | |
EPS in Rs | 1,107.25 | 1.05 | 2.77 | 4.65 | 2.86 | 2.45 | 3.31 | -3.85 | 6.54 | 13.00 | 20.77 | 21.10 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 41% | 30% | 0% | 15% | 19% | 19% | 21% |
Compounded Sales Growth | |
---|---|
10 Years: | 11% |
5 Years: | 10% |
3 Years: | 14% |
TTM: | 10% |
Compounded Profit Growth | |
---|---|
10 Years: | 35% |
5 Years: | 44% |
3 Years: | 47% |
TTM: | 2% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 45% |
3 Years: | 41% |
1 Year: | 37% |
Return on Equity | |
---|---|
10 Years: | 12% |
5 Years: | 16% |
3 Years: | 22% |
Last Year: | 21% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.33 | 200 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 |
Reserves | 569 | 595 | 753 | 854 | 916 | 963 | 962 | 885 | 1,021 | 1,264 | 1,636 | 1,981 |
321 | 289 | 152 | 120 | 491 | 499 | 607 | 551 | 533 | 644 | 1,011 | 1,595 | |
237 | 216 | 274 | 309 | 383 | 410 | 449 | 462 | 528 | 664 | 645 | 718 | |
Total Liabilities | 1,128 | 1,300 | 1,383 | 1,487 | 1,995 | 2,077 | 2,222 | 2,103 | 2,285 | 2,777 | 3,496 | 4,499 |
626 | 651 | 650 | 682 | 973 | 949 | 1,159 | 1,070 | 1,094 | 1,358 | 1,480 | 2,341 | |
CWIP | 12 | 9 | 13 | 52 | 30 | 56 | 3 | 5 | 23 | 32 | 34 | 27 |
Investments | 51 | 241 | 334 | 354 | 561 | 597 | 619 | 645 | 661 | 678 | 1,021 | 1,166 |
438 | 399 | 386 | 399 | 431 | 475 | 441 | 382 | 507 | 709 | 962 | 964 | |
Total Assets | 1,128 | 1,300 | 1,383 | 1,487 | 1,995 | 2,077 | 2,222 | 2,103 | 2,285 | 2,777 | 3,496 | 4,499 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
164 | 61 | 177 | 218 | 196 | 208 | 286 | 123 | 246 | 516 | 542 | ||
-172 | -192 | -130 | -162 | -446 | -137 | -129 | -12 | -117 | -621 | -761 | ||
5 | 127 | -2 | -32 | 226 | -11 | -170 | -114 | -57 | 65 | 237 | ||
Net Cash Flow | -3 | -4 | 46 | 25 | -24 | 61 | -12 | -3 | 72 | -40 | 19 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 45 | 40 | 34 | 31 | 37 | 28 | 24 | 34 | 26 | 22 | 21 | 25 |
Inventory Days | 63 | 55 | 46 | 42 | 41 | 36 | 24 | 19 | 18 | 17 | 28 | 19 |
Days Payable | 206 | 136 | 142 | 161 | 179 | 165 | 171 | 237 | 177 | 211 | 192 | 168 |
Cash Conversion Cycle | -98 | -41 | -62 | -88 | -102 | -101 | -124 | -184 | -133 | -172 | -143 | -124 |
Working Capital Days | -12 | 6 | 3 | -1 | -5 | -15 | -23 | -34 | -23 | -27 | -23 | 12 |
ROCE % | 9% | 7% | 11% | 15% | 9% | 8% | 9% | -4% | 15% | 23% | 23% | 19% |
Documents
Announcements
-
General Updates - Amended Code Of Conduct For Prohibition Of Insider Trading.
2h - FY25 audited results approved; final dividend Rs.4.50/share; debt issuance approval up to Rs.1,500 Cr.
-
General Updates - Amended Code Of Conduct For Prohibition Of Insider Trading.
2h - Audited FY25 results approved; Rs.4.50/share dividend recommended; Rs.1500 Cr debt issuance approved.
- Shareholders Meeting 2h
-
Announcement under Regulation 30 (LODR)-Change in Management
2h - Narayana Hrudayalaya reports FY25 audited results, declares Rs.4.50/share dividend, seeks Rs.1500 Cr debt issuance approval.
-
General Updates - Recommendation By The Board For The Issuance Of Non-Convertible Securities.
3h - Narayana Hrudayalaya reports FY25 audited results, Rs.4.50/share dividend, AGM on Aug 29, and Rs.1,500 Cr debt approval.
Annual reports
Concalls
-
May 2025TranscriptNotesPPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024TranscriptPPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT REC
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT REC
-
May 2023TranscriptPPT
-
May 2023Transcript PPT
-
May 2023TranscriptNotesPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Dec 2021TranscriptPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
Jun 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Nov 2020TranscriptNotesPPT
-
Aug 2020Transcript PPT
-
Aug 2020TranscriptNotesPPT
-
Jun 2020TranscriptNotesPPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Aug 2019Transcript PPT
-
Jun 2019Transcript PPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Aug 2018Transcript PPT
-
Jun 2018Transcript PPT
-
Feb 2018Transcript PPT
-
Jan 2018TranscriptNotesPPT
-
Nov 2017Transcript PPT
-
Aug 2017Transcript PPT
-
May 2017TranscriptNotesPPT
-
Nov 2016TranscriptPPT
-
Jul 2016TranscriptPPT
-
May 2016TranscriptNotesPPT
Hospital Portfolio[1][2]
- India: 19 owned/operated hospitals, 2 heart centers, 18 clinics, and dialysis centers.
- Cayman Islands: 1 hospital.
** - Total:** 40 healthcare facilities with 5,789 operational beds (including Cayman).